3636 results for «600»
3636 results
Challenging structural interventions #2
19 Dec 2024 – From GulfPCR-GIM 2024
Explore this session on challenging structural interventions, covering critical topics such as when to transition from the cath lab to the operating room, considerations around post-dilation when performing valve-in-valve procedures, strategies for preventing complications in TAVI for bicuspid aortic valve and coarctation of the aorta, as...
Align for the future with Myval THV series - From randomised trials to everyday clinical practice
19 Dec 2024 – From GulfPCR-GIM 2024
Stay ahead in TAVI innovation by exploring the advanced balloon-expandable Myval THV series. This session highlights the latest clinical data, optimal sizing and implantation techniques, and valuable real-world insights, including long-term follow-up results.
Left main bifurcation instent restenosis - LIVE case
18 Dec 2024 – From GulfPCR-GIM 2024
A 76-year-old male with a history of LM PCI (2-stent strategy), RCA PCI, reduced LV function (25%), diabetes, and CKD presented with worsening angina. Angiography revealed in-stent restenosis at the ostium of the LAD and CX, along with RCA occlusion.
The procedure was performed with axillary Impella...
Renal denervation in 2024
19 Dec 2024 – From GulfPCR-GIM 2024
Join us to explore advancements in renal denervation (RDN) technology and clinical applications. This session covers radiofrequency and ultrasound approaches, mechanisms, step-by-step procedures, patient selection, and program setup, offering insights into optimizing outcomes for hypertension patients.
Please note that this Case-in-a-Box does not reflect the recording standards...
Revolutionising coronary care: the impact of drug-coated balloons in acute and chronic artery disease - A stentless future
18 Dec 2024 – From GulfPCR-GIM 2024
Discover how drug-coated balloons (DCBs) are revolutionizing coronary care, with insights into their use in both acute and chronic artery disease management. Explore the potential for a stentless future as you learn about the role of DCBs in acute coronary events, their impact on chronic artery...
How to deal with PCI complications
18 Dec 2024 – From GulfPCR-GIM 2024
Interventional cardiology is not without its challenges. This session delves into the management of complex PCI complications, equipping you with the knowledge and techniques to prevent, recognize, and effectively handle life-threatening situations. From the dreaded 'no-flow' scenario to the most intricate perforations and massive thrombus burdens,...
When complications storm through the cathlab #2
19 Dec 2024 – From GulfPCR-GIM 2024
Brace yourself as we delve into a captivating session showcasing a series of complex and challenging complications that can arise in the catheterization laboratory. From a coiling gone awry to a stuck burr in an elderly patient, this session offers invaluable insights and strategies for navigating...
Interventional pot pourri #2
19 Dec 2024 – From GulfPCR-GIM 2024
This interventional potpourri session covers a diverse range of challenging cases in interventional cardiology. From a case of failed balloon angioplasty in a non-dilatable calcified lesion to an innovative approach for treating isolated side branch osteal lesions, this session offers valuable insights and practical solutions. Discover...
IVUS and OCT from the NAPs' perspectives
18 Dec 2024 – From GulfPCR-GIM 2024
This session offers a comprehensive exploration of the roles and perspectives of Non-Invasive Physiological Assessment (NAPA) specialists in the use of Intravascular Ultrasound (IVUS) and Optical Coherence Tomography (OCT) during interventional cardiology procedures. Gain insights into the key indications for IVUS and OCT, learn how to...
Complex non left main bifurcation PCI - LIVE case
19 Dec 2024 – From GulfPCR-GIM 2024
A 71-year-old male presented with angina (CCS 2), normal left ventricular function, and mitral stenosis. Coronary angiography revealed severe ostial stenosis of the circumflex artery and a significant LAD/diagonal bifurcation lesion (Medina 0.1.1).
The operators performed balloon valvuloplasty to treat the mitral stenosis, followed by LAD/diagonal PCI....
Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Ballon with Conventional Ballon Angioplasty for In-Stent Restenosis (AGENT IDE)
27 Oct 2023
Mirvat Alasnag provides her take on the AGENT IDE trial which was presented by Robert W. Yeh at TCT Congress 2023. This pivotal randomized trial compares the safety and efficacy of the AGENT DCB to conventional balloon angioplasty in patients with ISR. It is the first...
Author
The greatest advance in the next 40 years would be to remove the need for angioplasty
17 May 2017
Spencer B. King performed some of the first coronary angioplasty procedures in the USA—having recently received a thank-you from the first patient that he treated. He tells The Daily Wire that the steerable guidewire, rather than the stent, was the greatest advance in angioplasty and that...
Authors :
ALL-RISE: A large-scale, global randomized trial of coronary physiology derived from conventional angiography compared with an invasive pressure wire-based approach to guide PCI
28 Mar 2026
Mirvat Al Asnag provides her take on the ALL-RISE randomised trial presented by Ajay J. Kirtane at ACC.26 in New Orleans.
Author
COVID-19 vaccines: Burning questions from the community and real-world applicability
13 Jan 2021
View a number of questions of interest to the interventional cardiovascular community, as well as the real-world applicability of COVID-19 vaccine trials.
A randomized, placebo-controlled trial of chronic total occlusion PCI in stable angina - ORBITA-CTO trial
03 Apr 2026
Kalaivani Mahadevan provides an in-depth analysis of the ORBITA-CTO trial: a first-ever randomised, double-blind, placebo-controlled trial evaluating CTO PCI in stable angina patients.
She also interviewed principal investigators Sarosh Khan and John Davies following the LBCT Scientific Session at ACC.26 in New Orleans and simultaneous publication in...
Author
Author
Author
The AQUATIC trial: Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation
01 Sep 2025
Chiara De Biase provides her take on the results of AQUATIC presented by Martine Gilard at ESC Congress 2025 in Madrid.
Author
![The AQUATIC trial [Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation: Rationale for and design of the AQUATIC double-blind randomized trial]](https://www.pcronline.com/var/pcrov3/storage/images/pcronline/news/congress-coverages/esc/2025/aquatic-trial-quitting-versus-using-aspirin-therapy-patients-stabilized-cad-stenting-long-term-oral-anticoagulation/27448089-9-eng-GB/The-AQUATIC-trial-Assessment-of-quitting-versus-using-aspirin-therapy-in-patients-with-stabilized-coronary-artery-disease-after-stenting-who-requi_image_responsive_6.jpg)